Enliven Therapeutics (NASDAQ:ELVN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Enliven Therapeutics (ELVN) operate in?

Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Enliven Therapeutics Stock (NASDAQ: ELVN) stock price, news, charts, stock research, profile.

Open	$21.94
Close	$21.80
Volume / Avg.	169.97K / 217.51K
Day Range	$21.75 - $22.50
52 Wk Range	10.90 - 30.03
Market Cap	$1.07B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	34.33%
Days to Cover	26.84

Recent News

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.

Zacks

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst

HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwright gave a Buy rating with a $37 price target, projecting significant sales potential for Enliven's therapies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$21.94
Close	$21.80
Volume / Avg.	169.97K / 217.51K
Day Range	$21.75 - $22.50
52 Wk Range	10.90 - 30.03
Market Cap	$1.07B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	34.33%
Days to Cover	26.84

About Enliven Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Enliven Therapeutics (ELVN) stock?

You can purchase shares of Enliven Therapeutics (NASDAQ:ELVN) through any online brokerage.

View our list of the best stock brokerages

Who are Enliven Therapeutics (ELVN) competitors?

Other companies in Enliven Therapeutics’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS) and Phibro Animal Health (NASDAQ:PAHC).

What is the forecast, or price target, for Enliven Therapeutics (ELVN) stock?

Enliven Therapeutics has a consensus price target of $36.00.

What is the current price for Enliven Therapeutics (ELVN)?

The stock price for Enliven Therapeutics (NASDAQ: ELVN) is $21.8 last updated February 21, 2025 at 4:00 PM EST.

Does Enliven Therapeutics (ELVN) pay a dividend?

There are no upcoming dividends for Enliven Therapeutics.

When is Enliven Therapeutics (NASDAQ:ELVN) reporting earnings?

Enliven Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Enliven Therapeutics (ELVN) going to split?

There is no upcoming split for Enliven Therapeutics.

What sector and industry does Enliven Therapeutics (ELVN) operate in?

Enliven Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Enliven Therapeutics

Enliven Therapeutics (ELVN) Forecast